Here are relevant reports on : adult-diapers-market
-
Transcutaneous Monitors Market by Type (Adult Wound Healing, Neonatal Care), Application (Sleep Diagnostics, Respiratory Care, Plastic surgery) & End User (Hospitals, Speciality Clinic, Neonatal Intensive Care, Diagnostic Center) - Global Forecast to 2023
The global transcutaneous monitors market is expected to reach USD 206.9 million by 2023 from USD 154.6 million in 2018, growing at a CAGR of 6.0%. Increasing demand for non-invasive monitoring; rising risk of respiratory diseases; increasing healthcare expenditure in developing economies such as India, China, Brazil; and technological advancement leading to more accuracy are some of the major factors driving the growth of the global transcutaneous monitors market. These driving factors consequence to the rapid adoption of these new devices, thus propelling the market growth.
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
Sinus Dilation Devices Market by Product (Balloon Dilation Devices, Endoscope (Rhinoscope, Sinoscope), Handheld), Procedure (Standalone, Hybrid), Patient Type (Adult, Pediatric) & Patient Care Setting (Hospitals & ASC, ENT Office) - Global Forecast to 2027
The global sinus dilation devices market growth is primed to transition from USD 2.8 billion in 2022 to USD 3.8 billion by 2027, showcasing a strong CAGR of 6.6%. The expansion of this market is due in large part to the upsurge in cases of chronic sinusitis as well as growing healthcare spending. However, a lack of skilled ENT professionals is one of the challenges that may inhibit the growth of this market.
- Published: August 2022
- Price: $ 4950
- TOC Available:
-
Cerebrospinal Fluid Management Market by Product (Shunts (Ventriculoperitoneal, Ventriculoatrial, Adjustable Valve), External Drainage Systems (EVD, Lumbar Drainage)), End User (Pediatric, Adult, Geriatric) - Global Forecast to 2022
The global cerebrospinal fluid management market is projected to reach USD 1.56 Billion by 2022 from an estimated USD 1.26 Billion in 2017, at a CAGR of 4.4% during the forecast period. The growth of this market is majorly driven by factors such as the growing geriatric population and the high prevalence of hydrocephalus and the subsequent increase in the number of shunting procedures. The key players in the global cerebrospinal fluid (CSF) management market are Medtronic (Ireland), Integra (US), B. Braun (Germany), DePuy Synthes (US), Spiegelberg GmbH & Co. KG (Germany), SOPHYSA (France), Natus Medical Incorporated (US), Dispomedica GmbH (Germany), Delta Surgical Limited (UK), Argi Grup (Turkey), Moller Medical GmbH (Germany), G. SURGIWEAR LTD. (India), and Wellong Instruments Co., Ltd. (Taiwan).
- Published: May 2018
- Price: $ 4950
- TOC Available:
-
US Telehealth & Telemedicine Market by Function (Clinical Care, Teleconsult, RPM, Patient Engagement, Analytics), Application (TeleICU, Teleradiology, Telecardiology, Diabetes), Age (Adult, Pediatric), End User (Hospital, Payer, ASC) - Forecast to 2030
The US Telehealth & Telemedicine Market, valued at US$46.10 billion in 2024, stood at US$51.40 billion in 2025 and is projected to advance at a resilient CAGR of 10.2% from 2025 to 2030, culminating in a forecasted valuation of US$83.63 billion by the end of the period. In the US, permanent CMS reimbursement expansions and state-level payment parity laws are driving telehealth growth by securing fair, ongoing reimbursement comparable to in-person care.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Gummy Vitamins Market by Product Type (Multivitamins, Single Vitamins), Source (Animal, Plant), Packaging Type (Bottles & Jars, Pouches), Distribution Channel (Store-Based, Online), End User (Adult, Children), and Region - Global Forecast to 2025
According to MarketsandMarkets, the global gummy vitamins market is projected to reach USD 10.6 billion by 2025, recording a CAGR of 12.5% during the forecasting period. This report includes a study on the marketing and development strategies, along with the product portfolios of leading companies. It consists of profiles of leading companies, such as Church & Dwight Co. Inc. (US), Life Science Nutritionals (Canada), Bettera Brands LLC (US), Softigel (US), Nature's Way Products, LLC (US), Zanon Vitamec Inc. (US), Olly Public Benefit Corporation (US), Herbaland Naturals Inc. (Canada), Hero Nutritionals, LLC (US), SmartyPants Inc. (US), The Nature's Bounty Co. (US), IM Healthcare (India), Nutra Solutions (US), Makers Nutrition, LLC (US), Vitakem Nutraceutical Inc. (US), Bayer Group (Germany), The Clorox Company (US), Ernest Jackson (UK), Boscogen, Inc (US), and Santa Cruz Nutritionals Inc. (US).
- Published: October 2020
- Price: $ 4950
- TOC Available:
-
Enteral Feeding Devices Market By Type (Enteral Feeding Tubes, Nasogastric Tubes, Enteral Feeding Syringes, Nasal Feeding Tubes), Insertion Method, Age Group (Adult, Pediatric), Application (Oncology, Hypermetabolism), End User - Global Forecast to 2032
The global enteral feeding devices market, valued at US$3.12 billion in 2024, stood at US$3.27 billion in 2025 and is projected to advance at a resilient CAGR of 5.5% from 2024 to 2032, culminating in a forecasted valuation of US$4.76 billion by the end of the period. Market growth is driven by the increasing geriatric population, technological advancements, regulatory support, greater awareness of nutritional needs, and expansion in emerging economies.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Conjugate Vaccines Market by Disease (Pneumococcal, DTP, Meningococcal Disease), Type (Monovalent, Multivalent), End User (Adult, Pediatric) - Forecast to 2030
The global conjugate vaccines market, valued at US$15.86 billion in 2024, stood at US$15.25 billion in 2025 and is projected to advance at a resilient CAGR of 7.4% from 2025 to 2030, culminating in a forecasted valuation of US$21.77 billion by the end of the period. The conjugate vaccines market is growing rapidly, driven by the rising prevalence of bacterial infections like pneumococcal, meningococcal, and Hemophilus influenzae type b (Hib), rising government immunization programs and policies, innovations in vaccine technology such as multivalent formulations, increased regulatory approvals for new products, and growing investments in research, development, and international collaborations.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Enteral Feeding Devices Market, by Type (Administration sets, Nasogastric Tubes, Enteral Feeding Syringes, Nasal Feeding, Nasoduodenal), Insertion Method, Age Group (Adult, Pediatric), Application (Oncology, Respiratory), End User - Forecast to 2032
The Asia Pacific enteral feeding device market, valued at USD 0.76 billion in 2025, stood at USD 0.80 billion in 2026 and is projected to advance at a resilient CAGR of 6.8% from 2026 to 2032, culminating in a forecasted valuation of USD 1.20 billion by the end of the period. In the Asia Pacific enteral feeding devices market, the growth of enteral feeding tubes is primarily attributed to the incidence of diseases such as cancer, stroke, neurological disorders, and gastrointestinal diseases that often lead to swallowing difficulties and require prolonged nutrition support.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Medical Humidifier Market by Product (Heated, Heat & Moisture Exchangers, Humidifier Accessories), Application (ICUs , Neonatal Care),Distribution Channel (Online), Patient Type (Adult), End user (Hospitals) and Region - Global Forecast to 2029
Global medical humidifier market valued at $878.4M in 2023, reached $922.8M in 2024, and is projected to grow at a robust 5.6% CAGR, hitting $1,211.7M by 2029. The high growth rate of the APAC is attributed to the shift toward home healthcare due to cost savings and patient preference, rising birth rates & neonatal respiratory issues, and heavy investments in hospital infrastructure, ICU capacity, and medical device innovation.
- Published: March 2025
- Price: $ 4950
- TOC Available:
-
Europe Telehealth & Telemedicine Market by Function (Clinical Care, Teleconsult, RPM, Patient Engagement, Analytics), Application (TeleICU, Teleradiology, Telecardiology, Diabetes), Age (Adult, Pediatric), End User (Hospital, Payer) - Forecast to 2030
The Europe telehealth & telemedicine market, valued at US$22.01 billion in 2024, stood at US$24.76 billion in 2025 and is projected to advance at a resilient CAGR of 11.2% from 2025 to 2030, culminating in a forecasted valuation of US$42.04 billion by the end of the period. The growth of the Europe telehealth & telemedicine market is driven by the rising demand for remote healthcare services, increasing adoption of digital health platforms, and expanding broadband and mobile connectivity across the region.
- Published: November 2026
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
